---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Noom

🌎 noom.com

Noom is a leading behavior change company in the wellness and fitness services industry, focused on helping people achieve real, sustainable results in weight loss using a combination of technology, psychology, and personal coaching. The company offers behavior change courses, virtual diabetes prevention programs, and personalized plans tailored to individual biology and psychology.

---

Updates as of Sep 23, 2024

• Noom added Korean language support to their website.
• Jeremy Victor has been appointed as the Chief Customer Officer at Noom.
• Noom has appointed Rachel Mahoney as the new Chief Nrand Officer as it enters the off-label weight loss drug market.
• Jeremy Victor, Operations & Customer Experience Executive at Noom, announced that Noom has broadened access to important obesity medications.
• Noom announced it now offers a white-label version of Wegovy for $149 the first month and $279 per month thereafter, significantly cheaper than the branded version.

• Noom announced a new weight loss program offering compounded semaglutide starting at $149.
• Noom filed a trademark application on September 20, 2024, for nutritional supplements, dietary supplements, and anti-diabetic pharmaceuticals.
• Humanly uses Noom's existing company handbooks, PDFs, or data from public URLs to train bespoke chatbots.
• A study involving 240 cancer survivors found that the newly developed Engagement Index (EI) model outperformed the existing model in predicting long-term user engagement with the Noom app.

---

Did you find it useful?

If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.